Teva Pharmaceutical Industries Ltd- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltd簡介



公司代碼TEVA

公司名稱Teva Pharmaceutical Industries Ltd

上市日期Feb 06, 2087

CEOFrancis (Richard D)

員工數量33892

證券類型Depository Receipt

年結日Feb 06

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家Israel

郵編6944020

電話97239148213

網址https://www.tevapharm.com/

公司代碼TEVA

上市日期Feb 06, 2087

CEOFrancis (Richard D)

Teva Pharmaceutical Industries Ltd公司高管



名稱

名稱/職務

職務

持股

持股變動

Prof. Varda Shalev

Independent Director

22.50K

+42.80%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

Mr. Gerald M. (Jerry) Lieberman

Independent Director

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Roberto A. Mignone

Independent Director

--

Dr. Perry D. Nisen, M.D., Ph.D.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Prof. Varda Shalev

Independent Director

22.50K

+42.80%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

收入明細

單位: USD更新時間: 4月6日週一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Generic products

9.42B

54.59%

AUSTEDO

2.26B

13.10%

Other

1.51B

8.73%

Anda

1.50B

8.67%

AJOVY

673.00M

3.90%

其他

1.90B

11.01%

地區USD

名稱

營收

佔比

United States

9.19B

53.23%

Europe

5.04B

29.21%

International Markets

2.16B

12.53%

Other

870.00M

5.04%

業務

地區

業務USD

名稱

營收

佔比

Generic products

9.42B

54.59%

AUSTEDO

2.26B

13.10%

Other

1.51B

8.73%

Anda

1.50B

8.67%

AJOVY

673.00M

3.90%

其他

1.90B

11.01%

股東統計

更新時間: 2月19日週四

持股股東

股東類型

持股股東

佔比

Harel Insurance Investments and Financial Services Ltd

3.95%

Phoenix Investment and Finances Ltd

3.53%

WCM Investment Management

3.51%

Menora Mivtachim Insurance Ltd.

3.38%

Clal Insurance Enterprises Holdings Ltd.

3.21%

其他

82.43%

持股股東

佔比

Harel Insurance Investments and Financial Services Ltd

3.95%

Phoenix Investment and Finances Ltd

3.53%

WCM Investment Management

3.51%

Menora Mivtachim Insurance Ltd.

3.38%

Clal Insurance Enterprises Holdings Ltd.

3.21%

其他

82.43%

股東類型

持股股東

佔比

Investment Advisor

27.92%

Investment Advisor/Hedge Fund

12.90%

Hedge Fund

6.68%

Insurance Company

6.60%

Sovereign Wealth Fund

3.06%

Research Firm

2.16%

Pension Fund

1.74%

Bank and Trust

0.99%

Family Office

0.92%

其他

37.04%

機構持股



更新時間: 4月5日週日

報告期間

機構數

持股數

持股佔比

持股變動

2026Q1

1226

725.07M

62.27%

+9.19M

2025Q4

1170

665.23M

57.84%

-137.26M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Harel Insurance Investments and Financial Services Ltd

44.95M

3.86%

+7.26M

+19.25%

Dec 31, 2025

Phoenix Investment and Finances Ltd

41.09M

3.53%

-208.11K

-0.50%

Dec 31, 2025

WCM Investment Management

14.01M

1.2%

+13.76M

+5492.83%

Dec 31, 2025

Menora Mivtachim Insurance Ltd.

39.32M

3.38%

+395.89K

+1.02%

Dec 31, 2025

Clal Insurance Enterprises Holdings Ltd.

37.40M

3.21%

+5.92M

+18.79%

Dec 31, 2025

Migdal Insurance and Financial Holdings Ltd

37.40M

3.21%

+4.82M

+14.79%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

35.79M

3.07%

+870.38K

+2.49%

Dec 31, 2025

Norges Bank Investment Management (NBIM)

35.18M

3.02%

+33.32M

+1786.80%

Dec 31, 2025

Lingotto Investment Management LLP

28.42M

2.44%

-166.02K

-0.58%

Dec 31, 2025

Fidelity Management & Research Company LLC

23.59M

2.03%

+3.41M

+16.88%

Dec 31, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares MSCI Israel ETF

7.76%

VanEck Israel ETF

7.5%

VanEck Pharmaceutical ETF

3.79%

First Trust WCM Developing World Equity ETF

3.16%

First Trust WCM International Equity ETF

2.64%

ARK Israel Innovative Technology ETF

1.81%

WealthTrust DBS Long Term Growth ETF

1.42%

WisdomTree International Multifactor Fund

0.77%

iShares Health Innovation Active ETF

0.69%

iShares MSCI Intl Value Factor ETF

0.46%

iShares MSCI Israel ETF

佔比7.76%

VanEck Israel ETF

佔比7.5%

VanEck Pharmaceutical ETF

佔比3.79%

First Trust WCM Developing World Equity ETF

佔比3.16%

First Trust WCM International Equity ETF

佔比2.64%

ARK Israel Innovative Technology ETF

佔比1.81%

WealthTrust DBS Long Term Growth ETF

佔比1.42%

WisdomTree International Multifactor Fund

佔比0.77%

iShares Health Innovation Active ETF

佔比0.69%

iShares MSCI Intl Value Factor ETF

佔比0.46%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據